DeepSeek moment

As 2025 draws to a close, Wall Street’s love affair with Chinese equities is in full swing. While the relationship…

Numbers do not always tell the whole story. But they are revealing nonetheless. In 2013, direct investment transaction volumes in…

In the Capital Connectors series, exclusive interviews with six influential Chinese and global bankers reveal the opportunities and challenges for…

Chinese biotech firm Akeso, whose cancer drug has been hailed as a breakthrough for the nation’s pharmaceutical industry, suffered a…

Hong Kong’s market watchdog and stock exchange operator have set up a special communication channel and a new confidential filing…